Medicine And Health Products Industry Investment Exaggerated Wind Of The Change In Investment In The

“10,000 yuan create millionaires “,”×× franchisee has become a millionaire, the next one is you”, “a phone, you’re the next millionaire,” these slogans, become a medicine health industry a unique “landscape.” Most dealers are now considered as the first half of planners, this “dream come true”, that can Hude who lives? Rhetoric impure motives to those who will be exposed at the impetuous attitude, at best win laughed.

The author believes that the market model for investment must be done! Successful market start only model is the best proof of success, dealers will be carrying a “pocketbook” to seek them out.

Pharmaceutical industry is classified by international standards, international industry, one of the 15 categories, among the world’s fastest rising industry trade growth. But in China, the circulation of non-standard business practices, resulting in the pharmaceutical industry in the normal course of trading drugs lose the right to speak, seriously hampered the normal operation of industry. Facing the new situation in the industry, as pharmaceutical companies, the secret of their survival and development is changing! Business Pulse Resources

Integration The face of unregulated competition and management continue to introduce new policies, pharmaceutical companies, especially growing pharmaceutical companies in the fierce market competition, in not being swallowed, need flexible mechanisms and innovative thinking to deal with, the author This opened up the “prescriptions” are:

Growing pharmaceutical companies to share resources, a lot of money if the backlog in fixed assets, corresponding to the product development will bring financial pressure and risk. At this time, as enterprises should take the initiative, create opportunities, to seek strength, have the brand influence of large pharmaceutical companies as a processing base, so as to change the survival predicament. In fact, many famous companies also need this OEM and OEM production to enhance competitive advantage, to complete the value chain remodeling and recycling, or by mutual agreement, by the other party to the acquisition, merger, reorganization manner medium and small pharmaceutical companies into the Group’s overall strategy of operating system, small pharmaceutical companies to retain the original advantages of the technology and talent, flexible batch production of small, practical strength of a single species, to maximize the target market segments to meet the consumer demand, so as to large enterprises special complementary services, complementary energy advantage.

Root out the potential of small pharmaceutical companies with a number on the scale and prestige of the agents, distributors, so that they complement each other, what they want, with the latter’s capital, networks, channels do not have their own advantages, a professional production to ensure production quality. Outsourcing in marketing are also OEM for the other side, in order to save costs, reduce market risk and fully tap their potential.

Leveraging each other several small pharmaceutical companies to leveraging each other and establish a strategic development concept. Only a small amount of each investment, and its matching technology, business, logistics and other resources for horizontal integration, information sharing, channel communion, risk sharing, the rational use of personnel, which is conducive to a firm in the regional economy heel, to minimize waste of resources.

I am an expert from China Products, usually analyzes all kind of industries situation, such as black ceramic vase , green ceramic vase.

No related posts.